Blood and tissue docosahexaenoic acid (DHA, 22:6n-3) turnover rates from Ahiflower® oil are not different than from DHA ethyl ester oil in a diet switch mouse model.

Ahiflower® oil is high in α-linolenic and stearidonic acids, however, tissue/blood docosahexaenoic acid (DHA, 22:6n-3) turnover from dietary Ahiflower oil has not been investigated. In this study, we use compound-specific isotope analysis to determine tissue DHA synthesis/turnover from Ahiflower, flaxseed and DHA oils. Pregnant BALB/c mice (13-17 days) were placed on a 2 % algal DHA oil diet of high carbon-13 content (δ13C) and pups (n = 132) were maintained on the diet until 9 weeks old. Mice were then randomly allocated to a low δ13C-n-3 PUFA diet of either: 1) 4 % Ahiflower oil, 2) 4.35 % flaxseed oil or 3) 1 % fish DHA ethyl ester oil for 1, 3, 7, 14, 30, 60 or 120 days (n = 6). Serum, liver, adipose and brains were collected and DHA levels and δ13C were determined. DHA concentrations were highest (p < 0.05) in the liver and adipose of DHA-fed animals with no diet differences in serum or brain (p > 0.05). Based on the presence or absence of overlapping 95 % C.I.'s, DHA half-lives and synthesis/turnover rates were not different between Ahiflower and DHA diets in the liver, adipose or brain. DHA half-lives and synthesis/turnover rates from flaxseed oil were significantly slower than from the DHA diet in all serum/tissues. These findings suggest that the distinct Ahiflower oil n-3 PUFA composition could support tissue DHA needs at a similar rate to dietary DHA, making it a unique plant-based dietary option for maintaining DHA turnover comparably to dietary DHA.

Extraction efficiencies of heavy metals in hydroethanolic solvent from herbs of commerce.

Heavy metal contamination of herbal products is a major concern in the herbal and dietary supplement industry. Heavy metal exposure is well-documented to cause a variety of adverse human health effects and to negatively impact our environment. The Final Rule for Dietary Supplements for current good manufacturing practice regulation, 21 U.S. Food and Drug Administration Code of Federal Regulations 111, requires dietary supplement manufacturers to establish herbal purity limits for heavy metal contaminants considered safe for human consumption. Heavy metals may enter into the herbal manufacturing process via bioaccumulation from the harvest site or during postharvest processing phases, such as drying and/or liquid extraction. Traditionally, herbalists have used hydroethanolic solvents to extract herbal biomasses in pure food-grade ethanol-water combinations with solvent polarities capable of removing a wide range of hydrophilic and lipophilic constituents. The presented data demonstrate that hydroethanolic solvents are not completely efficient in the extraction of heavy metal accumulations from plant matrixes; and can act as an effective decontamination step in herbal product processing.